- cafead Jul 03, 2023 at 11:02: AM
via AbbVie’s Botox is a major blockbuster and king of the anti-wrinkle aesthetics market, but there are new contenders coming for its crown.
Revance, which markets its rival anti-wrinkle therapy Daxxify, is one of those battling for market share and is pulling no punches in its marketing war against Botox after officially launching its drug this year.
article source
Revance, which markets its rival anti-wrinkle therapy Daxxify, is one of those battling for market share and is pulling no punches in its marketing war against Botox after officially launching its drug this year.
article source